Antitumor antibiotic kedarcidin
CA 1338262 C · Owner: Bristol-Myers Squibb Company · Inventors: Forenza, Salvatore; Bush, James A.; Tomita, Koji
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Kedarcidin is a protein antitumor antibiotic produced by Streptoalloteichus sp. nov. strain L585-6 ATCC 53650. The antibiotic comprises a non-protein chromophore and a single chain polypeptide having 114 amino acid residues.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted April 23, 1996. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 23, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.